Abstract
Skeletal muscle contraction is triggered by the excitation-contraction (E-C) coupling machinery residing at the triad, a membrane structure formed by the juxtaposition of T-tubules and sarcoplasmic reticulum (SR) cisternae. The formation and maintenance of this structure is key for muscle function but is not well characterized. We have investigated the mechanisms leading to X-linked myotubular myopathy (XLMTM), a severe congenital disorder due to loss of function mutations in the MTM1 gene, encoding myotubularin, a phosphoinositide phosphatase thought to have a role in plasma membrane homeostasis and endocytosis. Using a mouse model of the disease, we report that Mtm1-deficient muscle fibers have a decreased number of triads and abnormal longitudinally oriented T-tubules. In addition, SR Ca2+ release elicited by voltage-clamp depolarizations is strongly depressed in myotubularin-deficient muscle fibers, with myoplasmic Ca2+ removal and SR Ca2+ content essentially unaffected. At the molecular level, Mtm1-deficient myofibers exhibit a 3-fold reduction in type 1 ryanodine receptor (RyR1) protein level. These data reveal a critical role of myotubularin in the proper organization and function of the E-C coupling machinery and strongly suggest that defective RyR1-mediated SR Ca2+ release is responsible for the failure of muscle function in myotubular myopathy.
Keywords: myotubular myopathy, triad
X-linked myotubular (centronuclear) myopathy (XLMTM; OMIM 310400) is a severe congenital disorder characterized by generalized muscle weakness and hypotonia often leading to poor vital prognosis during early infancy. XLMTM belongs to a group of muscular disorders named centronuclear myopathies (CNM) that share a common pathological feature in skeletal muscle, the presence of hypotrophic myofibers with internal nuclei (1–3). More than 200 loss-of-function mutations in the MTM1 gene, affecting all domains of the MTM1 gene product, myotubularin, have been identified in patients with myotubular myopathy (4–6). Myotubularin is a ubiquitously expressed phosphoinositide (PI) 3-phosphatase that acts on both phosphatidylinositol 3-phosphate [PI(3)P] and 3,5-bisphosphate [PI(3,5)P2] in vitro and in vivo (7–10). These signaling lipids play important functions in the endocytic pathway by regulating the temporal recruitment of proteins required for endosome maturation, protein sorting, and lysosomal degradation (11–13). Although the enzymatic and cellular functions of myotubularin have been investigated in cell lines, the specific role(s) of this protein in muscle cells remains unknown.
In autosomal cases of CNM, mutations have been found to date in the DNM2 gene encoding the large GTPase dynamin 2 (14) and in the BIN1 gene encoding amphiphysin 2 (15), two proteins known to regulate membrane remodeling and trafficking and implicated in endocytosis. In particular, amphiphysin 2 is localized at transverse (T)-tubules in muscle, and a muscle-specific isoform of amphyphisin 2 has membrane tubulation properties (16, 17). Recent expression studies in mouse have shown that myotubularin is partly associated with the triads of muscle fibers (18).
In skeletal muscle, triads are membrane structures composed of a T-tubule, which results from the onward invagination of the plasma membrane, and two terminal cisternae of sarcoplasmic reticulum (SR), where excitation-contraction (E-C) coupling occurs (19). In mammalian muscles, E-C coupling relies on a tight control of SR Ca2+ release via the type 1 ryanodine receptor (RyR1) by the voltage-sensing dihydropyridine receptor (DHPR). RyR1 is located at the junctional terminal cisternae of the SR and interacts with the DHPR complex. Depolarization of the T-tubule membrane causes a conformational change in the Cav1.1 subunit (DHPRα1) that directly activates the RyR1. This allows rapid mobilization of the SR Ca2+ store resulting in a rise in myoplasmic [Ca2+] that triggers contraction. Conversely, muscle relaxation occurs through Ca2+ re-uptake into the SR by ATP-dependent sarco(endo)plasmic reticulum Ca2+ pumps (SERCAs) (19).
Studies of rodent models deficient for Mtm1 have revealed that skeletal muscle is indeed the primary tissue involved in the pathogenesis of XLMTM and that myotubularin is essential for muscle growth and proper distribution of organelles in myofibers. Myotubularin knockout (KO) mice develop a CNM, starting at around 3–4 weeks of postnatal age, with progressive muscle weakness that severely reduces life expectancy to about 6–12 weeks (20). The molecular mechanisms responsible for these structural abnormalities and force deficit are currently unknown.
In this study, we investigated the mechanisms responsible for the loss of muscle function in XLMTM. We characterized the morphological and functional properties of the E-C coupling machinery in muscle fibers lacking myotubularin PIs phosphatase and uncovered structural anomalies of T-tubules and defects in SR calcium release, suggesting that E-C uncoupling is responsible for the muscle weakness in XLMTM.
Results
Abnormal Distribution of Triads in Myotubularin-Deficient Myofibers.
In this study, we used a constitutive Mtm1 KO line in the 129PAS background, because mutant mice develop a clinically more homogenous and severe CNM than previously characterized in C57/Bl6 KO mice (20). These mutant animals develop a progressive growth impairment, with a 10–15% reduction of weight during the first 4 postnatal weeks as compared to wild-type (WT) littermates, reaching about 30% from 5 weeks of age (see Fig. S1). Mtm1-deficient mice manifest a progressive muscle weakness, starting clinically at around 3–4 weeks, and most of them are dead by the age of 7 weeks (mean = 38.6 ± 7.1 days, range = 28–54, n = 11). In 5-week-old mutant mice, the weight of the tibialis anterior (TA) muscle is lower by 50% compared to controls, the corresponding mean cross-sectional area of myofibers is significantly smaller (554 μm2 in KO versus 1,260 μm2 in WT), and the percentage of internalized nuclei is 10 ± 3.9 compared to 1.6 ± 0.3 in WT mice (see Fig. S1). Fig. S1 also shows that the distribution of oxidative staining, which reflects the position of mitochondria and ER, is abnormal in mutant TA myofibers and adopts a “necklace” aspect with accumulation of staining in the subsarcolemmal region, as observed in XLMTM patients (21) and a “core-like” aspect, with reduction of staining in the center of fibers, as seen in myopathies due to RYR1 mutations (22). Central aggregation of NADH-TR staining (mitochondria), a hallmark of XLMTM pathology, is also observed.
Since myotubularin is partly associated with triads in skeletal muscle (18) and transcriptome studies from XLMTM murine muscle revealed disturbances in expression of some genes implicated in Ca2+ homeostasis including Cacng1 (2.2-fold up), Homer1 (2.4-fold down), Camk2D (3.2-fold up), Chrna1 (6.7-fold up), Rrad (61-fold up), and Sln (72-fold up), we investigated the E-C coupling machinery in this animal model. We analyzed at 5 weeks the distribution of triads by immunolabeling markers of T-tubules (DHPR) and terminal cisternae of SR (RyR1). The longitudinal SR membrane was monitored by SERCA1 ATPase labeling. We observed abnormal localization of some of these markers compared to WT muscles where they aligned as a typical striated pattern reflecting the organization of myofibrils (Fig. 1A). In Mtm1 KO muscles, DHPRα and RyR1 striations were disorganized with absence of labeling in some regions and occasional divergence from the transversal orientation, while SERCA1 distribution appeared mostly normal. This suggests a disorganization of both T-tubules and terminal SR cisternae.
We further analyzed the morphology of triads at the ultrastructural level by electron microscopy using potassium ferrocyanide as a selective staining procedure for T-tubules. In 5-week-old mutant TA myofibers, we found a significant proportion of tubules with longitudinal orientation that are aligned to the direction of myofibrils (Fig. 1B). This distribution is very rare in normal muscle at this age (less than 6% of total tubules) and was found in 11 out of 16 mutant fibers. Longitudinal (L)-tubules represents 25% of total tubules in analyzed KO myofibers (n = 16 fibers from both four WT and four Mtm1 KO mice) (Fig. 1C). We also measured the number of tubules (T- and L-tubules) per Z-line, which reflects the distribution of triads along myofibrils, and corresponds to about two in normal mature muscle cells. Fig. 1D shows that there is a 40% decrease in the number of triads in mutant fibers at this age (mean 1.09 ± 0.1 in KO versus 1.86 ± 0.03 in WT, P < 0.001).
To know whether these T-tubule abnormalities are already present at early stages of disease progression, we investigated 2-week-old KO mice. At this age, weakness could not be observed in hind limbs, but muscle weight was already decreased, mitochondria appeared partly mislocalized, and the percentage of internal nuclei was slightly increased in KO muscle (see Fig. S2). Indeed, L-tubules were also more frequent in mutants at this early stage of the disease from about 4% in WT to a mean value of 15% in KO fibers (Fig. 1E). In addition, we found that the number of tubules per Z-line was already lower by about 25% in Mtm1-deficient muscle fibers at this age (1.37 ± 0.07 and 1.81 ± 0.06 in KO and WT fibers, respectively, P < 0.001) (Fig. 1F).
Altogether, these results indicate that myotubularin is important for the proper organization of the T-tubules and triads in skeletal muscle and that triad disorganization is an early event in the pathogenesis of the disease in these mice that progresses over time.
Absence of Myotubularin Leads To Dysregulation of Genes Involved in Calcium Homeostasis.
We also examined the expression level of key regulators of the E-C coupling process in TA muscle. By using quantitative RT-PCR, we measured the mRNA level of the α1, β1, and γ1 subunits of the voltage-sensing DHPR (Cacna1s, Cacnb1, and Cacng1), the SR Ca2+ release channel type 1 ryanodine receptor (RyR1), type 1 and 2 SERCA pumps (Atp2a1, Atp2a2), and calsequestrin 1 and 2 (Casq1, Casq2), which encode the major Ca2+-buffering proteins in the lumen of striated muscle SR (23). In 5-week-old-mice, we found that Cacnb1 and Cacng1 mRNAs were significantly increased by 1.3- and 3-fold, respectively, whereas transcript level of Casq2 was decreased by about 30% (Fig. 2A). The expression of Cacng1 was already augmented in mutant muscle at 2 weeks of age (SI Methods and Fig. S3).
Given these data, we quantified DHPRα1, DHPRβ1, RyR1, SERCA1, and calsequestrin protein level in TA muscle of Mtm1 null mice during disease evolution. We found that the ryanodine receptor was strikingly reduced by 3-fold in microsomal preparations of KO muscles at 5 weeks of age and DHPRα1 was decreased by about 30%, whereas DHPRβ1 level was about 6-fold higher (Fig. 2B and Fig. S3). Discrepancies between the mRNA and protein levels of Ryr1 and Cacna1s may result from decreased protein stability, possibly due to an alteration in RYR1-DHPR interaction. All these proteins were also analyzed in muscle from 2-week-old mice, when weakness was not visible, and we found no significant differences between genotypes (see Fig. S3). These results demonstrate that dysregulation of components of the E-C machinery is a secondary and progressive process in murine myotubular myopathy.
Impaired SR Calcium Release in Muscle Fibers from Mtm1 KO Mice.
These observations led us to investigate the functional properties of E-C coupling in muscle fibers from 5-week-old mice. For these measurements, short muscle fibers that are easily amenable to voltage-clamp, were isolated from the flexor digitorum brevis (FDB) and interosseus muscles. In these muscles, we also obtained evidence for partial loss of T-tubules in mutant fibers using confocal imaging of di-8-anneps fluorescence (SI Methods and Fig. S4).
Figure 3A shows indo-1 calcium signals recorded from a representative control and Mtm1 mutant fiber, respectively. Ca2+ transients were triggered by voltage-clamp depolarizations of 5, 10, and 20 ms duration from −80 to +10 mV. The peak amplitude of the indo-1 transients was much smaller in the Mtm1-deficient fiber than in the control one, while the resting indo-1 level and the overall time-course of the transients were similar in the two fibers. Mean results from the indo-1 measurements on 14 fibers each revealed that the peak change in cytosolic calcium concentration (Δ[Ca2+]) was strongly depressed for all pulse durations in Mtm1-deficient fibers as compared to the values in control fibers (P ≤ 0.001) (Fig. 3B). Conversely resting [Ca2+] levels were unaffected (Fig. 3C). The overall calcium removal capability of the cytosol including SR Ca2+ uptake was estimated from the rate of [Ca2+] decay after the end of the pulses. Exponential fits to the [Ca2+] decay time course showed that the rate was significantly depressed (by ≈30%, P < 0.001) following 5-ms-long pulses in mutant muscle cells, but this was not the case after longer pulses (Fig. 3D). This lower rate at 5-ms-long pulses may result from the very low peak [Ca2+] levels (< 0.5 μM) reached in response to this pulse in KO fibers, considering the strong [Ca2+] dependence of the SR Ca2+ ATPase activity. To know whether the depressed peak Δ[Ca2+] in the Mtm1-deficient fibers resulted from a decreased SR calcium content, we determined the total amount of releasable calcium by measuring indo-1 signals in fibers equilibrated with a large concentration of intracellular EGTA and challenged by a series of voltage-clamp depolarizations applied in the presence of a SR Ca2+ pump inhibitor. Results showed that the mean SR Ca2+ content did not significantly differ between control and Mtm1-deficient fibers (SI Methods and Fig. S4).
We next tested whether the depressed Ca2+ release in Mtm1-deficient fibers was related to an alteration of the properties of the voltage-sensor of E-C coupling, the DHPR. The voltage-activated Ca2+ current through the DHPR was measured in WT and Mtm1-deficient fibers. Figure 4A shows representative calcium current traces from a WT and from an Mtm1-deficient fiber in response to 0.5-s-long depolarizing pulses to various levels. The corresponding mean peak Ca2+ current density versus voltage relationships from identical measurements performed in 16 WT and 20 KO fibers are shown in Fig. 4B. Surprisingly, the peak amplitude of the Ca2+ current was strongly reduced in the Mtm1-deficient fibers. Fitting the individual current-voltage curves by a Boltzmann function scaled by the driving force (24) showed that this reduction corresponded to a 37% depression in the mean value for the maximal conductance of the calcium channels (P < 0.03). Overall results demonstrate that myotubularin deficiency is responsible for a severe functional alteration of both DHPR-mediated Ca2+ entry and RyR1-mediated SR Ca2+ release.
Discussion
In the present study, we show that absence of myotubularin in skeletal muscle induces alterations in the architecture of T-tubules and triads and a severe impairment of depolarization-induced Ca2+ release from the SR that is expected to lead to a reduced Ca2+-troponin occupancy and thus to depressed contraction and force development.
The XLMTM mouse model used here reproduces major features of the corresponding human disease, including muscle weakness and hypotrophy, presence of internal nuclei in myofibers and fatal outcome within a few weeks after birth. The clinical and pathological evolution of the myopathy is more homogenous and also more severe in the 129PAS background than in the previously characterized C57/Bl6 XLMTM mice (20). We found that muscles are already affected in mice at 2 weeks of age as they contain hypotrophic fibers with altered distribution of triads, mitochondria, and, to some extent, nuclei. However, weakness was not yet apparent at this age. Importantly, as morphological abnormalities precede weakness, it suggests that defects noted at 2 weeks represent a primary event in disease pathogenesis.
Strikingly, we found an abnormal proportion of longitudinally oriented T-tubules and a reduced number of T-tubules/triads in Mtm1-deficient skeletal muscle, a phenomenon that increased over time. Abnormal oblique and longitudinal T-tubules have also been observed in muscle biopsies from some XLMTM patients (25). Longitudinal tubules are normally present in developing muscle before being rearranged, and this transition to a full transverse orientation occurs between birth and 3 weeks postnatally in mice (26). The presence of increased numbers of L-tubules and reduction of triads in 2-week-old Mtm1-deficient muscle suggests that the final rearrangement of this membranous system during early postnatal life does not occur properly in the absence of myotubularin. Although the molecular function of myotubularin in skeletal muscle is not well understood, additional findings support a role of myotubularin in T-tubule/SR network morphogenesis and/or remodeling. We previously showed that overexpression of myotubularin in myofibers alters plasma membrane homeostasis, leading to the accumulation of membrane saccules and vacuoles positive for sarcolemma markers (18). Moreover, amphiphysin 2, encoded by the BIN1 gene is mutated in autosomal recessive cases of CNM, and its Drosophila ortholog is involved in the structural organization of the membrane compartment of the E-C coupling machinery (15, 27). The similar defects found both in our Mtm1 KO mouse and in amphiphysin Drosophila mutants strongly support the existence of a common myotubularin-amphiphysin pathway regulating T-tubule biogenesis in muscle. Preliminary results indicate that the localization of amphiphysin 2 at the triad is partially decreased (manuscript in preparation). Caveolin 3 was also implicated in T-tubule biogenesis and is mutated in different forms of muscle diseases including limb-girdle muscular dystrophy type 1C (LGMD1C) (28, 29), highlighting the importance of this structure for human muscle function. Finally, while preparing this manuscript, a paper has described abnormalities in T-tubule organization in muscles from a zebrafish model of myotubular myopathy and patients (30).
Our analysis uncovered quantitative anomalies at mRNA and protein level in expression of genes related to the control of intracellular Ca2+ homeostasis. In skeletal muscle, myoplasmic Ca2+ concentration is tightly regulated, and its alteration severely affects muscle function (31, 32). The most striking change in myotubularin-deficient muscles was a drastic drop in the protein level of RyR1 Ca2+ release channel. Along this line, we found that Ca2+ release from the SR was strongly depressed in myotubularin-deficient fibers. Notably, the role of RyR1 in the pathogenesis of CNM is further supported by the recent finding of a de novo mutation in the RYR1 gene in a patient with an autosomal dominant form (33). In contrast, we found that myoplasmic Ca2+ removal processes remained largely unaffected in Mtm1-deficient fibers, as demonstrated from our measurements of the rate of Ca2+ removal, SR Ca2+ content, and expression level of SERCA1. Our results also revealed that the SR Ca2+ release dysfunction in Mtm1-deficient fibers was associated with a decrease in the calcium channel activity of the DHPR, which is likely due to the decrease in DHPRα1 protein level at the T-tubule membrane. In addition, the drop of RyR1 Ca2+ release channel protein may also contribute to this effect, because RyR1 per se was previously shown to be responsible for a retrograde coupling mechanism that specifically enhances the function of DHPR as a voltage-dependent calcium channel (34). The decrease in DHPRα1 protein level in Mtm1 KO fibers may result from the drop in RyR1 level. Accordingly, skeletal muscle from mice lacking RyR1 was shown to exhibit a 2-fold reduction in the number of dihydropyridine binding sites. We also found an increase of DHPRβ1 and γ1 subunits mRNA. When examined at the protein level, DHPRβ1 subunit was up-regulated by 6-fold in 5-week-old mutants. The β1 subunit appears essential for the assembly of DHPR in arrays of tetrads at the junctional membrane (35), binds to RYR1, and strengthens E-C coupling (36). It is likely that the increased DHPRβ1 level in Mtm1 KO muscle results from a compensatory mechanism intended to promote targeting of newly expressed α1 subunits to the triad and facilitate E-C coupling.
Taken together, our data favor a role of myotubularin in the physical organization of the E-C coupling machinery, at the T-tubules, and/or SR. However, we cannot exclude that it may also act directly on RyR1 channel function and/or protein transport and stability. For instance, mice deficient for mitsugumin-29 display similar ultrastructural abnormalities, but only minor defects in muscle strength (37). Myotubularin activity on PI(3)P and/or PI(3,5)P2 could also play a direct role on channel activation, as previously reported for a homologous protein, MTMR6, which regulates the activity of the Ca2+-activated K+ channel KCa3.1 via PI(3)P (38, 39). Other mutant mice with deletions in genes involved in triad formation and/or calcium homeostasis, such as junctophilin 1 and triadin, also contain muscles with abnormally oriented T-tubules and alterations in Ca2+ transients and/or E-C coupling (40) (41). In conclusion, we propose that alterations in the structure of triads and defects in calcium homeostasis are the main cause of muscle weakness in centronuclear/myotubular myopathy. Manipulation of intracellular calcium in patient muscles may represent a therapeutic strategy.
Methods
Skeletal Muscle T-Tubule Labeling.
WT and Mtm1 KO mice in the 129PAS background were used in this study. Care and manipulation of mice were performed in accordance with national and European legislations on animal experimentation.
Immunohistochemistry.
Anesthetized mice [by i.p. injection of 5 μL per body gram of ketamine (20 mg/mL; Virbac) and xylazine (0.4%, Rompun; Bayer)] were perfused with 4% paraformaldehyde before muscle dissection. Semithin sections (500-nm) of muscle were prepared as previously described (18). We used monoclonal antibodies directed against DHPRα1 (Cav1.1) subunit (MA3–920; Affinity Bioreagents), RyR (clone 34C; Sigma), and SERCA1 ATPase (MA3–911; ABR).
Electron Microscopy.
Selective staining of T-tubules in TA muscle was modified from (26). Briefly, muscles were dissected from anesthetized mice and fixed in 2.5% paraformaldehyde, 2.5% glutaraldehyde, and 50 mM CaCl2 in 0.1 M cacodylate buffer (pH 7.4). Samples were postfixed with 2% OsO4, 0.8% K3Fe(CN)6 in 0.1 M cacodylate buffer (pH 7.4) for 2 h at 4 °C and incubated with 5% uranyl acetate for 2 h at 4 °C. Muscles were dehydrated in a graded series of ethanol and embedded in epon resin. Thin (70-nm) sections were stained with uranyl acetate and lead citrate and examined by transmission electron microscope. The length of longitudinally oriented T-tubules and number of triads per Z-line were quantified with Metamorph 3 software from electron micrographs (magnification 9,800× and 5,600× for muscles of 5- and 2-week-old mice, respectively).
Quantitative RT-PCR Analysis.
Total RNA was purified from muscles of 2- and 5-week-old male mice using TRIzol reagent (Invitrogen) according to manufacturer's instructions. cDNA was synthetized from 2–5 μg total RNA using SuperScript II reverse transcriptase (Invitrogen) and random hexamers. Quantitative PCR amplifications of cDNA were performed on Light-Cycler 480 and Light-Cycler 24 instruments (Roche) using 58 °C as melting temperature. Primer sequences for amplification are provided as SI Methods.
Immunoblot Analysis
Microsome Preparations.
Frozen muscles were homogenized in 200 mM sucrose, 20 mM HEPES, 0.4 mM CaCl2, pH 7.4, and protease inhibitors (1 mM PMSF, 100 μg/mL leupeptine) using a dounce tissue grinder (Wheaton). The supernatant obtained by centrifugation at 1,500 × g for 10 min, was further centrifuged at 41,000 × g for 50 min, and microsomes were resuspended in 0.1 M NaCl, 30 mM imidazole, 8% sucrose, pH 6.8, with protease inhibitors. All preparation steps are performed at 4 °C. Proteins were quantified with the Bio-Rad Laboratories Protein Assay detection kit and transferred to nitrocellulose membranes after electrophoresis in either 8 or 10% SDS polyacrylamide gels. Bands were scanned from photographic films by the Chemi Genius2 imaging system, and quantification was performed using GeneTools software (SynGene). The amount of protein was normalized against GAPDH as loading control.
Antibodies.
Purified rabbit polyclonal antibody against mouse myotubularin was generated as previously described (18). We also used monoclonal antibodies directed against RyR1 (clone 34C; Sigma), DHPRβ subunit (VD21 B12; Developmental Studies Hybridoma Bank), SERCA1 ATPase (MA3–911; Affinity Bioreagents), calsequestrin (MA3–913; Affinity Bioreagents), glyceraldehyde-3-phosphate dehydrogenase (MAB374; Chemicon). Secondary horseradish peroxidase-conjugated antibodies against mouse and rabbit IgG (Jackson ImmunoResearch Laboratories) were detected using the ECL chemiluminescent reaction (Pierce).
Electrophysiology and Intracellular Calcium Measurements.
Experiments were performed on single skeletal fibers from the FDB and interosseus muscles using previously described methods and analytical procedures (42–44), see SI Methods for further details.
Statistical Analysis.
Data were statically analyzed using paired Student t-test. Values were considered significant when P ≤ 0.05. Growth curves of mice were analyzed by ANOVA.
Supplementary Material
Acknowledgments.
We thank Yannick Schwab, Josiane Hergueux, and Yasmine Yucel for help in histological studies; all members of Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) mouse house facility for help in animal care; and the Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, for providing VD21 B12 ascite. This study was supported by funds from the Institut National de la Santé et de la Recherche Médicale, the Centre National de la Recherche Scientifique, the Hôpital Universitaire de Strasbourg (HUS), the Collège de France and by grants from the Association Française contre les Myopathies (AFM), the Agence Nationale de la Recherche (ANR) and the Fondation pour la Recherche Médicale (FRM), the National Institutes of Health (P50 NS040828), the Joshua Frase Foundation, and the Lee and Penny Anderson Family Foundation. L.A.-Q. was supported by fellowships from the Syrian Ministry of High Education and the FRM.
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/cgi/content/full/0900705106/DCSupplemental.
References
- 1.Wallgren-Pettersson C, et al. The myotubular myopathies: Differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J Med Genet. 1995;32:673–679. doi: 10.1136/jmg.32.9.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pierson C, Tomczak K, Agrawal P, Moghadaszadeh B, Beggs AH. X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol. 2005;64:555–564. doi: 10.1097/01.jnen.0000171653.17213.2e. [DOI] [PubMed] [Google Scholar]
- 3.Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008;3:26. doi: 10.1186/1750-1172-3-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Laporte J, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13:175–182. doi: 10.1038/ng0696-175. [DOI] [PubMed] [Google Scholar]
- 5.Laporte J, et al. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat. 2000;15:393–409. doi: 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
- 6.Biancalana V, et al. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet. 2003;112:135–142. doi: 10.1007/s00439-002-0869-1. [DOI] [PubMed] [Google Scholar]
- 7.Blondeau F, et al. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet. 2000;9:2223–2229. doi: 10.1093/oxfordjournals.hmg.a018913. [DOI] [PubMed] [Google Scholar]
- 8.Taylor G, Maehama T, Dixon J. Inaugural article: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA. 2000;97:8910–8915. doi: 10.1073/pnas.160255697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tronchère H, et al. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem. 2004;278:7304–7312. doi: 10.1074/jbc.M311071200. [DOI] [PubMed] [Google Scholar]
- 10.Cao C, Backer J, Laporte J, Bedrick E, Wandinger-Ness A. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell. 2008;19:3334–3346. doi: 10.1091/mbc.E08-04-0367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.DiPaolo G, DeCamilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657. doi: 10.1038/nature05185. [DOI] [PubMed] [Google Scholar]
- 12.Robinson F, Dixon J. Myotubularin phosphatases: Policing 3-phosphoinositides. Trends Cell Biol. 2006;16:403–412. doi: 10.1016/j.tcb.2006.06.001. [DOI] [PubMed] [Google Scholar]
- 13.Nicot A, Laporte J. Endosomal phosphoinositides and human diseases. Traffic. 2008;9:1240–1249. doi: 10.1111/j.1600-0854.2008.00754.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bitoun M, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37:1207–1209. doi: 10.1038/ng1657. [DOI] [PubMed] [Google Scholar]
- 15.Nicot A, et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007;39:1134–1139. doi: 10.1038/ng2086. [DOI] [PubMed] [Google Scholar]
- 16.Butler M, et al. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol. 1997;137:1355–1367. doi: 10.1083/jcb.137.6.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lee E, et al. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science. 2002;297:1193–1196. doi: 10.1126/science.1071362. [DOI] [PubMed] [Google Scholar]
- 18.Buj-Bello A, et al. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet. 2008;17:2132–2143. doi: 10.1093/hmg/ddn112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Karpati G, Hilton-Jones D, Griggs R. Disorders of Voluntary Muscle. Cambridge, UK: Cambridge University Press; 2001. [Google Scholar]
- 20.Buj-Bello A, et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci USA. 2002;99:15060–15065. doi: 10.1073/pnas.212498399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bevilacqua J, et al. “Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol. 2009;117:283–291. doi: 10.1007/s00401-008-0472-1. [DOI] [PubMed] [Google Scholar]
- 22.Treves S, Jungbluth H, Muntoni F, Zorzato F. Congenital muscle disorders with cores: The ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol. 2008;8:319–326. doi: 10.1016/j.coph.2008.01.005. [DOI] [PubMed] [Google Scholar]
- 23.Beard N, Laver D, Dulhunty A. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol. 2004;85:33–69. doi: 10.1016/j.pbiomolbio.2003.07.001. [DOI] [PubMed] [Google Scholar]
- 24.Collet C, Csernoch L, Jacquemond V. Intramembrane charge movement and L-type calcium current in skeletal muscle fibers isolated from control and mdx mice. Biophys J. 2003;84:251–265. doi: 10.1016/S0006-3495(03)74846-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sarnat H. Myotubular myopathy: Arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci. 1990;17:109–123. doi: 10.1017/s0317167100030304. [DOI] [PubMed] [Google Scholar]
- 26.Franzini-Armstrong C. Simultaneous maturation of transverse tubules and sarcoplasmic reticulum during muscle differentiation in the mouse. Dev Biol. 1991;146:353–363. doi: 10.1016/0012-1606(91)90237-w. [DOI] [PubMed] [Google Scholar]
- 27.Razzaq A, et al. Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev. 2001;15:2967–2979. doi: 10.1101/gad.207801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Parton R, Way M, Zorzi N, Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol. 1997;136:137–154. doi: 10.1083/jcb.136.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Minetti C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998;18:365–368. doi: 10.1038/ng0498-365. [DOI] [PubMed] [Google Scholar]
- 30.Dowling J, et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet. 2009;5:e1000372. doi: 10.1371/journal.pgen.1000372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gissel H. The role of Ca2+ in muscle cell damage. Ann N Y Acad Sci. 2005;1066:166–180. doi: 10.1196/annals.1363.013. [DOI] [PubMed] [Google Scholar]
- 32.Dulhunty A. Excitation-contraction coupling from the 1950s into the new millennium. Clin Exp Pharmacol Physiol. 2006;33:763–772. doi: 10.1111/j.1440-1681.2006.04441.x. [DOI] [PubMed] [Google Scholar]
- 33.Jungbluth H, et al. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2007;17:338–345. doi: 10.1016/j.nmd.2007.01.016. [DOI] [PubMed] [Google Scholar]
- 34.Nakai J, et al. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature. 1996;380:72–75. doi: 10.1038/380072a0. [DOI] [PubMed] [Google Scholar]
- 35.Schredelseker J, et al. The beta 1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle. Proc Natl Acad Sci USA. 2005;102:17219–17224. doi: 10.1073/pnas.0508710102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cheng W, Altafaj X, Ronjat M, Coronado R. Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling. Proc Natl Acad Sci USA. 2005;102:19225–19230. doi: 10.1073/pnas.0504334102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nishi M, et al. Abnormal features in skeletal muscle from mice lacking mitsugumin29. J Cell Biol. 1999;147:1473–1480. doi: 10.1083/jcb.147.7.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Srivastava S, et al. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1. Mol Cell Biol. 2005;25:3630–3638. doi: 10.1128/MCB.25.9.3630-3638.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Srivastava S, et al. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. Mol Biol Cell. 2006;17:146–154. doi: 10.1091/mbc.E05-08-0763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ito K, et al. Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J Cell Biol. 2001;154:1059–1067. doi: 10.1083/jcb.200105040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shen X, et al. Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J Biol Chem. 2007;282:37864–37874. doi: 10.1074/jbc.M705702200. [DOI] [PubMed] [Google Scholar]
- 42.Jacquemond V. Indo-1 fluorescence signals elicited by membrane depolarization in enzymatically isolated mouse skeletal muscle fibers. Biophys J. 1997;73:920–928. doi: 10.1016/S0006-3495(97)78124-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Collet C, Allard B, Tourneur Y, Jacquemond V. Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J Physiol. 1999;520:417–429. doi: 10.1111/j.1469-7793.1999.00417.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pouvreau S, Jacquemond V. Nitric oxide synthase inhibition affects SR Ca2+ release in skeletal muscle fibres from mouse. J Physiol. 2005;567:815–823. doi: 10.1113/jphysiol.2005.089599. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.